ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
GSK plc ADRhedged
69.80
+2.83
4.23%
成交量：
858
成交額：
5.98萬
市值：
69.81萬
市盈率：
- -
高：
70.05
開：
69.80
低：
69.34
收：
66.97
52周最高：
85.03
52周最低：
55.75
股本：
1.00萬
流通股本：
1.00萬
量比：
4.75
換手率：
8.58%
股息：
2.08
股息率：
2.98%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
GSK十年來最大一筆併購，對中國Biotech的四點啓示
蓝鲸财经
·
06/11
重返腫瘤核心戰場 葛蘭素史克(GSK.US)能否借Nuvalent縮小與阿斯利康差距？
智通财经网
·
06/11
「納什維爾計劃」：葛蘭素史克以110億美元收購Nuvalent，加速腫瘤業務重建
路透中文
·
06/11
6月10日美股成交額前20：Nuvalent獲GSK收購，股價飆升逾39%
环球市场播报
·
06/10
Nuvalent股價飆升 此前GSK宣佈收購該公司
环球市场播报
·
06/09
葛蘭素史克百億收購Nuvalent，肺癌靶向藥管線再落重子
环球市场播报
·
06/09
【美股盤前】黃仁勳喊話「買高通股票」，高通升逾3%；被谷歌與英偉達列為備選代工廠，英特爾升逾1%；蘋果AI版Siri亮相，市場不買賬股價微跌；OpenAI已遞交IPO申請
每日经济新闻
·
06/09
數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易
路透中文
·
06/09
溢價40%！葛蘭素史克擬以106億美元收購Nuvalent，加碼癌症藥物領域
智通财经
·
06/09
最高溢價近43%!葛蘭素史克(GSK.US)擬斥資90-100億美元收購腫瘤藥企Nuvalent(NUVL.US)
智通财经
·
06/09
最高溢價近43%！葛蘭素史克擬斥資90-100億美元收購腫瘤藥企Nuvalent
智通财经
·
06/09
港股異動 | 中國生物製藥(01177)升逾4% 與GSK合作的Bepirovirsen將於EASL 2026公布兩項III期臨床數據
智通财经
·
05/29
全球首項乙肝功能性治癒藥物三期數據來了：這類患者，治癒率可達35%
第一财经
·
05/28
重磅ADC藥物獲批多發性骨髓瘤二線聯合用藥，GSK中國特藥業務部負責人：腫瘤是未來GSK重要增長引擎之一
蓝鲸财经
·
05/19
流行病診療板塊多股揚升 雅培(ABT)漲1.60%、強生(JNJ)漲1.12%
金吾财讯
·
05/12
中國生物製藥升逾4%：牽手GSK合作乙肝臨床治癒明星產品
澎湃新闻
·
05/11
正大天晴牽手GSK，瞄準乙肝百億美元賽道商業化棋局
21世纪经济报道
·
05/11
中國生物製藥牽手葛蘭素史克 佈局乙肝新藥在華商業化
财中社
·
05/11
時安生物與GSK就寡核苷酸新藥達成超10億美元授權合作；莎普愛思終止購買上海勤禮實業100%股權｜醫藥早參
每日经济新闻
·
05/07
葛蘭素史克(GSK)股票4月29日盤中下跌5.22%：關鍵驅動因素揭曉
TradingKey中文
·
04/30
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/GSKH/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.8025,"timestamp":1789416000000,"preClose":66.9705,"halted":0,"volume":858,"delay":0,"changeRate":0.042287275740811155,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"盤前交易","change":2.832,"latestTime":"09-15 06:26:37 EDT","open":69.8,"high":70.05,"low":69.34,"amount":59772,"amplitude":0.010602,"askPrice":110.98,"askSize":100,"bidPrice":28.06,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":69.8025,"nav":66.979706,"aum":669864.039706,"dividendRate":0.0298,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"volumeRatio":4.745572596475333,"impliedVol":0.1896,"impliedVolPercentile":0.4737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.745572596475333,"shares":10001,"dividePrice":2.0801,"high":70.05,"amplitude":0.010602,"preClose":66.9705,"low":69.34,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.8025,"eps":0,"divideRate":0.0298,"volume":858,"delay":0,"ttmEps":0,"open":69.8,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":69.5112,"twentyDayClose":68.9018,"sixtyDayClose":73.2027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642286033","title":"GSK十年來最大一筆併購，對中國Biotech的四點啓示","url":"https://stock-news.laohu8.com/highlight/detail?id=2642286033","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642286033?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 18:59","pubTimestamp":1781175583,"startTime":"0","endTime":"0","summary":"这事儿，挺值得咱们中国的Biotech琢磨琢磨的。过去十年，中国创新药习惯了自己的坐标系。中国Biotech肯定不缺科学，但这种跳出自身坐标系、站在买家视角重新丈量自己价值的自觉，或多或少差了些。这对咱们中国Biotech第二个启示，就是别再净那些“万金油”式的东西了。而GSK这次可不一样。这，或许就是那张价值106亿美元倒计时牌，给咱们的Biotech上的最好一课。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1781143796640652546","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XBI","GSKH","GSK.UK","GSK","BK4007","LU1829250122.USD","BK4532","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642189402","title":"重返腫瘤核心戰場 葛蘭素史克(GSK.US)能否借Nuvalent縮小與阿斯利康差距？","url":"https://stock-news.laohu8.com/highlight/detail?id=2642189402","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642189402?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 15:56","pubTimestamp":1781164594,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，葛兰素史克以创纪录的106亿美元收购美国生物技术公司Nuvalent，此举将加快这家英国制药巨头旗下抗癌药物业务的重建步伐，以应对来自更大竞争对手阿斯利康和罗氏的竞争压力。米尔斯在周二宣布收购Nuvalent后对记者表示。葛兰素史克并不打算在全部肿瘤领域与默沙东、阿斯利康或罗氏正面竞争，但将其视为潜在的增长领域。收购Nuvalent将为葛兰素史克产品组合增添两款晚期药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4568","LU2237443978.SGD","LU0889565916.HKD","BK4139","LU2237443465.HKD","LU2237443895.HKD","LU0058720904.USD","LU2237443622.USD","LU0109394709.USD","LU2237443549.SGD","BK4532","GSK.UK","LU2462157665.USD","BK4588","BK4539","LU0289739699.SGD","LU0320765992.SGD","GSK","LU2456880835.USD","NUVL","LU2237443382.USD","LU1829250122.USD","IE00B3T34201.USD","BK4007","LU2236285917.USD","GSKH","BK4585","LU2417539215.USD","AZN","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642740679","title":"「納什維爾計劃」：葛蘭素史克以110億美元收購Nuvalent，加速腫瘤業務重建","url":"https://stock-news.laohu8.com/highlight/detail?id=2642740679","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642740679?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 14:00","pubTimestamp":1781157654,"startTime":"0","endTime":"0","summary":"“纳什维尔计划”：葛兰素史克以110亿美元收购Nuvalent，加速肿瘤业务重建此项交易进一步深化了首席执行官卢克·米尔斯领导下的肿瘤业务布局提振投资者信心，认为GSK有望实现2031年销售目标投资者认为GSK可能需要更多交易才能在肿瘤领域追赶竞争对手 Bhanvi Satija/Sabrina Valle. 这项代号为“纳什维尔”的收购是葛兰素史克迄今为止最大的一笔收购 ，将带来两种可能于今年在美国获批的肺癌治疗药物。Nuvalent的收购将为其产品组合增添两款晚期药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nL4S42J0F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","GSK","LU1829250122.USD","GSKH","BK4539","NUVL","BK4585","BK4007","BK4588","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642490845","title":"6月10日美股成交額前20：Nuvalent獲GSK收購，股價飆升逾39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642490845","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642490845?lang=zh_tw&edition=fundamental","pubTime":"2026-06-10 04:43","pubTimestamp":1781037780,"startTime":"0","endTime":"0","summary":"周二美股成交额第1名美光科技收跌1.41%，成交654.81亿美元。将于6月24日发布2026财年第三季度财报，期权市场正在为其股价可能出现约20%的大幅波动定价，这反映出投资者对这家AI内存芯片巨头业绩的高度期待与紧张情绪。 第17名Nuvalent收高39.28%，股价创历史新高，成交63.54亿美元。消息面上，葛兰素史克宣布同意以106亿美元的价值收购Nuvalent。声明指，GSK将以每股124美元现金收购Nuvalent，较后者周一收市价溢价40%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-10/doc-iniawawf4763180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4539","BK4139","NUVL","GSKH","BK4007","BK4588","GSK","GSK.UK","BK4585","BK4532","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642671094","title":"Nuvalent股價飆升 此前GSK宣佈收購該公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2642671094","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642671094?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 20:10","pubTimestamp":1781007000,"startTime":"0","endTime":"0","summary":"英国生物制药公司葛兰素史克宣布以106亿美元收购美国药企Nuvalent，后者股价随即飙升近39%。\n 这项全现金交易对Nuvalent的估值约为每股124美元。Nuvalent目前有两款治疗某种肺癌的药物正在接受美国食品药品监督管理局的审评。\n 葛兰素史克首席执行官卢克·米尔斯在新闻稿中表示，此次收购将为公司带来即时的新的销售增长机遇。这家药企在美国上市的股票周二盘前交易中下跌1%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-09/doc-iniavmyr1715814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NUVL","BK4007","BK4139","BK4539","BK4532","LU1829250122.USD","GSK","BK4588","GSKH","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642467330","title":"葛蘭素史克百億收購Nuvalent，肺癌靶向藥管線再落重子","url":"https://stock-news.laohu8.com/highlight/detail?id=2642467330","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642467330?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 20:00","pubTimestamp":1781006459,"startTime":"0","endTime":"0","summary":"英国制药巨头葛兰素史克周二宣布，已达成协议以106亿美元收购美国生物技术公司Nuvalent。受此消息刺激，Nuvalent股价盘前大涨近39%，逼近每股124美元的收购报价。 根据协议，GSK将以每股124美元现金收购Nuvalent所有流通股，较该公司周一收盘价溢价约40%。 Nuvalent成立于2017年，专注于精准靶向抗癌药物的研发。此前GSK多笔交易以显著溢价接盘中后期管线，若临床数据不及预期，可能面临商誉减值压力。该交易预计于今年第三季度完成，尚需获得监管批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-09/doc-iniavmyp4934270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4007","BK4539","NUVL","BK4588","LU1829250122.USD","GSK.UK","BK4532","GSKH","GSK","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642645594","title":"【美股盤前】黃仁勳喊話「買高通股票」，高通升逾3%；被谷歌與英偉達列為備選代工廠，英特爾升逾1%；蘋果AI版Siri亮相，市場不買賬股價微跌；OpenAI已遞交IPO申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2642645594","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642645594?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 18:39","pubTimestamp":1781001590,"startTime":"0","endTime":"0","summary":"①【三大期指涨跌不一】截至发稿，道指期货跌0.16%，标普500指数期货涨0.3%，纳指期货涨1.58%。②【OpenAI已递交IPO申请，奥尔特曼公布未来发展“三大目标】6月8日，OpenAI宣布已向美国证券交易委员会秘密递交美股IPO申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606093765254591.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765254591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1429558221.USD","LU0795875086.SGD","SG9999014542.SGD","LU1291159041.SGD","LU1206712785.SGD","LU0149725797.USD","LU0444971666.USD","BK4574","LU0097036916.USD","LU0069063385.USD","IE000M9KFDE8.USD","LU1303367103.USD","LU1803068623.USD","BK4585","BK4609","IE00BQXX3C00.GBP","LU0203347892.USD","LU2294711713.HKD","LU0820561909.HKD","LU0208291251.USD","2NVD.UK","LU0994945656.USD","LU0784385840.USD","LU0289960550.SGD","LU1815333072.USD","LU1116320901.HKD","LU1934455277.USD","SG9999014880.SGD","IE00BHPRN162.USD","LU1791710582.SGD","BK4534","IE000BZT7R73.USD","IE000ITXATA3.USD","LU2750360641.GBP","LU2746668461.USD","IE0009G5SDU7.USD","LU0949170426.SGD","NVDS","LU2237957811.SGD","IE0034235295.USD","LU2471134523.USD","LU0942090050.USD","BK4566","LU2249611893.SGD","LU0157215616.USD","APLY","LU0784383803.USD","LU0496365809.HKD","IE000KEQY171.SGD","LU0251131958.USD","IE00BQXX3F31.USD","LU2326559502.SGD","LU1629891620.HKD","LU0256863811.USD","LU0859254822.USD","LU0820562030.AUD","LU1127390331.HKD","LU2102340556.USD","LU0109391861.USD","IE0004086264.USD","BK4592","LU0251132253.USD","LU1880398471.USD","LU2381873111.SGD","LU0820561818.USD","APLX","LU0011850046.USD","IE000MB6IJN5.SGD","SG9999014898.SGD","LU2065171311.SGD","IE00B4YYXB79.USD","LU2097829019.USD","LU1084165304.USD","NVDW","LU0545039389.USD","BK4116","LU0719512351.SGD","LU2097344431.USD","MACW.SI","LU2417539215.USD","LU0477156797.USD","LU2133065610.SGD","BK4573","LU0128525929.USD","LU1064131342.USD","LU0130103400.USD","LU2347655156.SGD","LU1066051225.USD","SG9999015986.USD","LU1551013342.USD","LU2764262908.HKD","LU0174119429.USD","BK4529","LU2999663052.SGD","IE00B1BXHZ80.USD","LU1829250122.USD","LU2433249047.HKD","LU0868494617.USD","LU2111349929.HKD","LU0786609619.USD","LU1496350502.SGD","LU0345770993.USD","LU0976567544.SGD","LU0965509010.AUD","LU2237443622.USD","LU2471134952.CNY","LU0320765489.SGD","ANV","LU0348723411.USD","LU0106261372.USD","LU1917777945.USD","LU2089985449.USD","LU2265009873.SGD","IE00BZ1G4Q59.USD","LU1261432733.SGD","IE00BZ199S13.USD","BK4139","LU1430594728.SGD","LU1992135399.USD","SG9999017495.SGD","AAPY","LU1815336760.USD","LU2023250504.SGD","SG9999014559.SGD","LU1852331112.SGD","LU1989764664.SGD","LU0320765059.SGD","LU0158827781.USD","LU1043141396.HKD","IE00B1XK9C88.USD","LU1983260115.SGD","SG9999004303.SGD","LU1582986433.USD","LU1242518931.SGD","LU1989771016.USD","IE00BJJMRY28.SGD","IE00BYXW3230.USD","LU1196500208.SGD","IE00BVYPNQ40.USD","IE00B3S45H60.SGD","SG9999015952.SGD","LU2458330169.SGD","SG9999014906.USD","LU0211326839.USD","LU1868836757.USD","LU0302445910.USD","LU0316494557.USD","LU1582986359.USD","LU2362541513.USD","LU1732799900.SGD","LU2361044949.HKD","GOU","NVD2.UK","LU0738911758.USD","LU2237957902.USD","LU1582987324.SGD","LU0124676726.USD","LU0130517989.USD","LU0211327993.USD","LU1119994496.HKD","HK0000304797.USD","IE00B19Z3581.USD","AAPD","LU1823568750.SGD","APLD","LU0426412945.USD","AAPU","LU0154236417.USD","LU2286300806.USD","LU2471134796.USD","BK4575","NVDL","IE00BJTD4N35.SGD","LU0061475181.USD","LU1267930227.SGD","AAPX","BK4505","IE00B19Z8W00.USD","LU2362540622.SGD","LU2896262040.SGD","LU0648000940.SGD","LU0957791311.USD","SGXZ99366536.SGD","LU1221951046.USD","LU2063271972.USD","LU0080751232.USD","BK4538","NVYY","LU1923622291.USD","LU1202635105.USD","LU0466842654.USD","BK4514","LU2471134879.HKD","LU2462591277.SGD","LU0889566641.SGD","SG9999000418.SGD","LU2168564065.EUR","LU2361044865.SGD","GSKH","LU0225283273.USD","LU2083900584.USD","07388","LU2360106780.USD","LU2404859667.USD","LU0345774631.USD","LU1280957306.USD","BK4543","IE00B5949003.HKD","LU1301847155.USD","LU0979878070.USD","LU1880398554.USD","LU1066053197.SGD","LU2168564149.EUR","LU0690374961.EUR","BK4605","LU1316542783.SGD","LU2756315664.SGD","LU2065170008.USD","IE00B775SV38.USD","IE00BQXX3D17.EUR","BK4554","LU0128525689.USD","LU2756315318.SGD","LU1992135472.HKD","NUVL","LU1323610961.USD","LU2931357623.SGD","NVD","LU0130102774.USD","LU2404859741.USD","LU0308772762.SGD","LU1923623000.USD","LU0795875169.SGD","AAPW","IE0009356076.USD","LU0094547139.USD","LU1814569148.SGD","IE00BN29S564.USD","BK4527","NVDG","LU0557290698.USD","LU0234572021.USD","LINT","NVDD","LU1712237335.SGD","LU0056508442.USD","LU2087621335.USD","IE00B7SZLL34.SGD","LU2430703251.USD","IE0004445015.USD","LU2322448957.HKD","QCOM","LU1496350171.SGD","LU1244550221.USD","IE00BN8TJ469.HKD","LU2236285917.USD","LU0251142724.SGD","LU0690374615.EUR","LU1839511570.USD","LU1868837300.USD","LU0345774391.USD","LU0057025933.USD","LU0211326755.USD","LU2360032135.SGD","IE000SO60NU8.SGD","LU2461242641.AUD","LU0210533765.USD","LU1232071149.USD","LU0787776722.HKD","LU2247934214.USD","LU0708995401.HKD","LU1988902786.USD","LU2272731865.HKD","LU2413666426.HKD","LU1366192091.USD","IE0001KFT4U8.USD","BK4579","BK4170","HK0000532082.HKD","BK4023","LU0661504455.SGD","LU2250418816.HKD","LU1623119135.USD","LU1670756490.USD","LU0689626769.HKD","LU1066051498.USD","LU2237443382.USD","HK0000306685.HKD","LU2720916845.USD","LU2065169927.USD","BK4612","LU2487616109.SGD","LU1267930730.SGD","QCMD","LU2506951792.HKD","LU0672654240.SGD","LU1267930813.SGD","LU1951200564.SGD","LU0345768740.USD","LU0882574139.USD","SG9999014914.USD","IE00BDCRKT87.USD","LU0289961442.SGD","LU0345770308.USD","LU1670627923.USD","LU1732800096.USD","LU1674673691.USD","LU1821325948.USD","LU2087625088.SGD","IE00BGHQDM52.EUR","LU0053666078.USD","LU0082616367.USD","BK4581","LU1868836914.USD","LU2954938101.SGD","GSK","BK4561","LU0642271901.SGD","LU2125154778.USD","LU0314106906.USD","LU2028103732.USD","LU1043141123.HKD","3NVD.UK","LU3102509885.SGD","LU1066051811.HKD","LU2552382058.USD","IE000Q6AESB8.SGD","LU1582987597.SGD","QCMU","LU0528227936.USD","LU1934455863.HKD","BK4567","GB00B4QBRK32.GBP","LU0210528500.USD","GSK.UK","LU0345769128.USD","07788","LU0784385170.HKD","IE0004091025.USD","LU2089284900.SGD","LU0070302665.USD","LU1069344957.HKD","LU1201861165.SGD","LU2491050154.USD","LU0390134368.USD","LU2148611432.USD","LU0289739343.SGD","LU0823421333.USD","LU2125909916.SGD","LU2746668974.SGD","IE000YTNTUN2.SGD","LU0210536198.USD","HK0000819398.USD","LU1894683348.USD","NVDY","NVII","BK4141","LU0724617625.USD","APLZ","LU0312595415.SGD","LU0912757837.SGD","LU0323240290.USD","LU0310800379.SGD","LU0472753341.HKD","LU2357125470.USD","LU2463028550.USD","IE0002270589.USD","LU2211815571.USD","LU0321505868.SGD","LU1244550494.USD","LU1551013425.SGD","LU0203345920.USD","LU0949170772.SGD","LU0648001328.SGD","LU1046421795.USD","LU0476273544.USD","LU2237443465.HKD","LU1506573853.SGD","LU0081259029.USD","LU0965508806.USD","LU2394011477.USD","BK4604","LU0070217475.USD","LU2458330243.SGD","LU0889565833.HKD","LU2602419157.SGD","NVDA","IE00BDRTCR15.USD","HK0000306701.USD","IE0005OL40V9.USD","IE00BMPRXR70.SGD","LU1244550577.SGD","LU0823421416.USD","LU2108987350.USD","LU0345768153.USD","IE00B19Z9505.USD","IE00BK4W5L77.USD","LU0353189763.USD","IE000W1ABFV2.USD","LU1935042488.USD","LU0345769631.USD","SG9999018865.SGD","LU2191332357.HKD","IE00B3SWFQ91.USD","SGXZ51526630.SGD","LU0788109477.HKD","LU1894683264.USD","LU0347712357.USD","IE00BMPRXQ63.HKD","LU1633808545.USD","LU0868494708.USD","LU2420271590.USD","AAPL","IE00BLSP4452.SGD","LU2054465674.USD","BK4553","LU0323239441.USD","LU2242649171.HKD","LU2764263203.CNY","LU0133085943.USD","LU0314104364.USD","LU2023250330.USD","SG9999015358.SGD","LU0079474960.USD","LU0640476718.USD","LU2322448791.USD","BK4587","NVDB","LU2023251221.USD","LU1242518857.USD","BK4608","LU1804176565.USD","LU1791710400.SGD","LU1121112475.USD","LU1778281490.HKD","IE00BMPRXN33.USD","BK4571","SGXZ23171101.USD","BK4559","BK4507","LU0276348264.USD","LU1935042991.SGD","LU1974910355.USD","LU0965509283.SGD","HK0000320223.HKD","LU2362541273.HKD","IE00BFSS7M15.SGD","LU0965509101.SGD","LU1861220033.SGD","IE00BKPKM429.USD","SGXZ31699556.SGD","LU2168564222.USD","LU0256863902.USD","GOOGL","BK4548","IE0034235303.USD","NVIW.SI","IE00BKVL7J92.USD","LU0187121727.USD","LU2023250843.SGD","LU1206713676.USD","QCML","LU0456855351.SGD","SG9999015341.SGD","BK4512","BK4549","LU1861127337.USD","IE0000B7K699.USD","BK4602","LU0708994859.HKD","BK4614","LU0048584097.USD","LU2462157665.USD","LU2237443895.HKD","LU0211328371.USD","LU1951198990.SGD","BK4007","LU0198837287.USD","LU1935043536.SGD","BK4501","LU1585245621.USD","LU2089283258.USD","BK4588","LU0211331839.USD","LU0689472784.USD","LU0861579265.USD","LU2237438978.USD","LU1935042215.USD","LU1153585028.USD","LU0266013472.USD","NVDX","GOOP","LU0477156953.USD","LU2360107168.USD","SG9999014567.USD","GOOY","SG9999002224.SGD","LU0354030511.USD","LU2047632596.USD","IE00BLSP4239.USD","LU1720051108.HKD","BK4515","LU0823434583.USD","IE00B7KXQ091.USD","LU1934455194.USD","LU0823434740.USD","LU2097344357.USD","LU1400636574.HKD","LU1803068979.SGD","LU2106854487.HKD","LU0158827948.USD","LU1989772923.USD","GB00B4LPDJ14.GBP","LU1718418525.SGD","LU1721428933.USD","LU1935043023.USD","LU2505996509.AUD","NVDO","LU2264538146.SGD","LU2361045086.USD","IE00B19Z8X17.USD","LU2100268510.USD","LU2272731782.SGD","LU0109392836.USD","LU2092937148.SGD","NVDQ","LU0138981039.USD","LU1003077747.HKD","LU1868837136.USD","LU1548497426.USD","LU0006306889.USD","LU2272731600.USD","LU0170899867.USD","LU1674673428.USD","LU2491049909.HKD","LU2552382132.HKD","BK4535","IE00BFMHRM44.USD","LU1400636657.SGD","SG9999001424.SGD","BK4576","GB00BDT5M118.USD","IE00BSNM7G36.USD","LU1645745479.HKD","LU2125909759.SGD","LU1032955483.USD","SNVD.UK","LU0323591593.USD","LU0127658192.USD","LU2237443549.SGD","GOOX","LU1868836591.USD","LU2357627491.SGD","BK4598","IE0003U64NQ7.SGD","LU2750360997.AUD","INTW","LU0072462426.USD","LU0792757196.USD","BK4503","LU1037948897.HKD","LU2637965513.SGD","IE000WAW04H5.SGD","BK4077","SG9999018857.SGD","HK0000914686.HKD","SG9999015978.USD","LU0553294199.USD","LU2168563687.JPY","LU0265550946.USD","IE00BWXC8680.SGD","LU1989772840.SGD","NVD3.UK","LU1267930490.SGD","LU1923622614.USD","LU0354030438.USD","LU2452424414.USD","SG9999002232.USD","IE00BFSS8Q28.SGD","LU0052756011.USD","LU0265550359.USD","LU2543165471.USD","NVDS.UK","IE00BJTD4V19.USD","LU0310799852.SGD","LU0823414478.USD","LU0143551892.USD","GGLS","LU0342679015.USD","LU1914381329.SGD","LU2347655073.USD","LU1221951129.SGD","LU1235294995.USD","LU1267930573.SGD","LU2098885051.SGD","HK0000320264.USD","LU0096364046.USD","LU2168564495.EUR","LU2592432038.USD","LU1037948541.HKD","LU0175139822.USD","LU2552382215.SGD","LU1059921491.USD","LU2092627202.USD","LU1670628061.USD","LU2125909593.SGD","LU0274383776.USD","LU1699723380.USD","IE0004445239.USD","LU2456880835.USD","LU0238689110.USD","NVDU","BK4533","LU1642822529.SGD","SG9999014575.USD","LU2403377893.USD","IE00B4JS1V06.HKD","LU0061474960.USD","IE00B775H168.HKD","LU0964807845.USD","GGLL","LU0215105999.USD","LU1989764748.USD","GOOW","LU0203201768.USD","LU1861215975.USD","LU2237443978.SGD","LU2860962120.EUR","LU2242650005.HKD","LU2290526834.HKD","IE000F7OJYX1.SGD","LU0511384066.AUD","BK4539","LU0957808578.USD","IE00BD6J9T35.USD","LU0726765562.USD","LU1366333091.USD","LU2125154935.USD","LU2462591350.SGD","IE00BBT3K403.USD","LU0321505439.SGD","LU2357305700.SGD","IE00B19Z3B42.SGD","LU0203202063.USD","LU0061474705.USD","LU0742534661.SGD","LU2505996681.GBP","LU0784384876.USD","BK4550","IE00BVYPNP33.GBP","LU2491050071.SGD","LU2213496289.HKD","HK0000914660.USD","LU2125909247.SGD","LU0823414551.USD","DIPS","IE00BKDWB100.SGD","LU1571399168.USD","IE00BK4W5M84.HKD","LU0985320562.USD","SGXZ81514606.USD","BK4532","LU0077335932.USD","LU2473716301.USD","LU0029864427.USD","LU1145028129.USD","LU2413666699.HKD","IE0034235188.USD","LU2065171402.SGD","LU2430703095.HKD","LU1720051017.SGD","LU0353189680.USD","LU0683600562.USD","LU0096362180.USD","LU2764263039.SGD","SG9999015945.SGD","LU0943347566.SGD","IE00BJLML261.HKD","LU0234570918.USD","LU0426417589.USD","HK0000304805.HKD","IE00B3M56506.USD","LU0048573561.USD","LU0310800965.SGD","LU2077746001.SGD","LU0980610538.SGD","LU2244417387.USD","LU1201861249.SGD","LU0107464264.USD","LU0417517546.SGD","LU1116320737.USD","LU2275660780.HKD","LU0130518102.USD","LU0267386448.USD","LU1400636491.USD","LU1691799644.USD","LU2271345857.HKD","LU1035775433.USD","INTC","BK4551","LU1435385759.SGD","LU0444973449.USD","04335","IE00BJJMRX11.SGD","LU2430703178.SGD","LU0494093205.USD","AAPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642146511","title":"數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2642146511","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642146511?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 17:14","pubTimestamp":1780996486,"startTime":"0","endTime":"0","summary":"路透6月9日 - 葛兰素史克 GSK.L 已同意以106亿美元 收购抗癌药物开发商Nuvalent NUVL.O，这是该英国制药商近年来最大的一笔交易，旨在加强其产品线并支持长期营收增长。此举进一步丰富了过去十年间美国制药公司为获取从肿瘤学、神经学到罕见病及肥胖症等领域有前景疗法而进行的一系列高调交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nL4S42H0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","GSKH","BK4585","GSK.UK","NUVL","LU1829250122.USD","BK4539","BK4139","GSK","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450645","title":"溢價40%！葛蘭素史克擬以106億美元收購Nuvalent，加碼癌症藥物領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450645","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450645?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 15:37","pubTimestamp":1780990654,"startTime":"0","endTime":"0","summary":"6月9日，$葛兰素史克$同意以106亿美元的价格收购肿瘤治疗药企Nuvalent。$葛兰素史克$周二发布声明称，将以每股124美元现金收购Nuvalent，较这家总部位于马萨诸塞州$剑桥$的公司周一收盘价溢价40%。此次收购标志着葛兰素史克癌症业务的重大扩张。Nuvalent的两款主要药物用于治疗携带特定基因突变的非小细胞肺癌患者。葛兰素史克表示，在获得监管部门批准后，对Nuvalent的收购预计将于第三季度完成。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451912.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"溢价40%！葛兰素史克拟以106亿美元收购Nuvalent，加码癌症药物领域","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GSK","BK4539","BK4139","BK4588","NUVL","GSKH","BK4532","BK4007","BK4585","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642567024","title":"最高溢價近43%!葛蘭素史克(GSK.US)擬斥資90-100億美元收購腫瘤藥企Nuvalent(NUVL.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642567024","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642567024?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 11:18","pubTimestamp":1780975127,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，葛兰素史克正就收购肿瘤治疗药企Nuvalent Inc.进行磋商，交易对价在90亿至100亿美元之间。本次交易将对总部位于马萨诸塞州剑桥市的Nuvalent给出高额溢价，这也将成为葛兰素史克史上规模最大的收购案之一。在退出肿瘤领域多年后，葛兰素史克近期才重新回归这一赛道。今年1月，葛兰素史克曾同意以22亿美元收购一家专注于炎症与免疫疾病治疗药物研发的美国生物科技公司Rapt Therapeutics，并在另一笔交易中获得了一款肺动脉高压药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NUVL","BK4007","BK4139","BK4539","BK4532","LU1829250122.USD","GSK","BK4588","GSKH","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195440784","title":"最高溢價近43%！葛蘭素史克擬斥資90-100億美元收購腫瘤藥企Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=1195440784","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195440784?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 09:14","pubTimestamp":1780967654,"startTime":"0","endTime":"0","summary":"6月9日，癌症生物技术公司Nuvalent夜盘涨超16%。据市场消息，葛兰素史克正就收购Nuvalent进行谈判，交易作价可能超过90亿美元，双方目标在本周内达成协议。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1451825.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["GSKH","NUVL","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639644648","title":"港股異動 | 中國生物製藥(01177)升逾4% 與GSK合作的Bepirovirsen將於EASL 2026公布兩項III期臨床數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2639644648","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639644648?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 14:33","pubTimestamp":1780036423,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国生物制药涨超4%，截至发稿，涨3.95%，报5港元，成交额4.28亿港元。消息面上，5月29日，中国生物制药发布公告，本集团附属公司正大天晴药业集团股份有限公司与葛兰素史克合作的Bepirovirsen，已公布其用于治疗慢性乙型肝炎的积极关键数据。Bepirovirsen目前正在接受中国、美国、欧洲、日本监管机构的审评审批。GSK预计2027年上半年收到中国国家药品监督管理局的监管决定，目前上市准备工作正在进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","BK4532","GSKH","LU1829250122.USD","HK0000165453.HKD","BK1589","BK4585","VXUS","III","GSK.UK","BK4588","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1191","BK4007","GSK","BK1521","BK1515","BK4134","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698093","title":"全球首項乙肝功能性治癒藥物三期數據來了：這類患者，治癒率可達35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698093","media":"第一财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698093?lang=zh_tw&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969642,"startTime":"0","endTime":"0","summary":"被视为有可能成为全球首款乙肝功能性治愈药物的贝普若韦生（Bepirovirsen），三期临床研究结果揭晓了。5月28日，葛兰素史克（GSK）在欧洲肝病学会（EASL）年会上公布了反义寡核苷酸（ASO）药物贝普若韦生两项全球三期临床试验（B-Well1和B-Well2）结果。结果也发表在全球顶刊《新英格兰医学杂志》上。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605283752957045.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283752957045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4561","BK4532","GSK.UK","GSKH","NA","LU1829250122.USD","BK4007","BK4585","BK4588","ASO","BK4141","GSK","BK4200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636356678","title":"重磅ADC藥物獲批多發性骨髓瘤二線聯合用藥，GSK中國特藥業務部負責人：腫瘤是未來GSK重要增長引擎之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2636356678","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636356678?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 15:41","pubTimestamp":1779176518,"startTime":"0","endTime":"0","summary":"值得注意的是，倍乐锐是GSK肿瘤领域的重磅药物。据GSK全球一季度财报，该药物在今年一季度收入达2300万英镑，在该款药物的加持下，肿瘤业务也已经是GSK当前业绩增长最快的板块。今年第一季度，GSK肿瘤业务销售额同比增长28%，达到5.12亿英镑，业务增速在所有业务中位居第一。GSK副总裁、中国特药业务部负责人张宁向蓝鲸新闻表示，GSK未来会考虑布局更多的ADC药物、小分子药物等形成合力，包括肿瘤在内的特药业务是未来GSK很重要的增长引擎之一。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779176429659930072","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4532","ADC","BK4585","GSKH","BK4231","BK4080","BK4588","GSK.UK","BK4007","GSK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634101862","title":"流行病診療板塊多股揚升 雅培(ABT)漲1.60%、強生(JNJ)漲1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634101862","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634101862?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 22:05","pubTimestamp":1778594751,"startTime":"0","endTime":"0","summary":"金吾财讯 | 汉坦病毒疫情叠加药企药物研发/合作进展向好消息提振，美股流行病诊疗板块多股扬升，截至发稿，葛兰素史克 涨 1.93%，雅培 涨 1.60%，默沙东 涨 1.41%，阿斯利康 涨 1.18%，强生 涨 1.12%。达歌生物周二宣布与默沙东研发(中国)有限公司签署合作协议，共同推进抗肿瘤药物临床合作开发。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MzZmY2I0ODMyNDljNDZhYjk1YmMwYzA2ZTYzZmI3NWMyMTczNjIzMDYxMjY4Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004303.SGD","SG9999014575.USD","GSKH","LU2347655156.SGD","LU0689626769.HKD","LU2505996509.AUD","BK4534","LU0109394709.USD","LU1196500208.SGD","LU0070217475.USD","IE00BGHQF631.EUR","JNJ","LU2133065610.SGD","LU1941712264.USD","LU0792757196.USD","LU0820561818.USD","LU1267930813.SGD","LU1934455194.USD","LU2471134879.HKD","IE00BLSP4452.SGD","LU2023250504.SGD","LU2211815571.USD","SG9999014559.SGD","LU0648001328.SGD","LU0787776722.HKD","LU2236285917.USD","LU0889566641.SGD","LU1037948897.HKD","LU2430703178.SGD","LU2106854487.HKD","GSK","LU1894683348.USD","IE00BDGV0183.EUR","LU1116320901.HKD","LU0265550359.USD","LU0124676726.USD","IE00B7SZLL34.SGD","LU0426412945.USD","LU0943347566.SGD","LU2237957902.USD","IE000M9KFDE8.USD","LU0965509283.SGD","LU2237443465.HKD","LU1917777945.USD","LU0640476718.USD","LU2237443382.USD","ABT","LU2750360641.GBP","IE0002270589.USD","LU0320765646.SGD","LU0122379950.USD","LU0234572021.USD","BK4568","IE00BJJMRZ35.SGD","LU0912757837.SGD","LU1201861249.SGD","LU0466842654.USD","LU1066051498.USD","LU1228905540.USD","LU1778281490.HKD","LU1691799644.USD","LU2129689431.USD","LU2361044949.HKD","LU1974910355.USD","LU0106261372.USD","LU0006306889.USD","LU1069347547.HKD","SGXZ23171101.USD","LU0683600562.USD","LU0210528500.USD","LU1674673428.USD","LU0965508806.USD","LU2505996681.GBP","LU2471134796.USD","IE00B2B36J28.USD","LU1244550577.SGD","AZN","LU1145028129.USD","LU1894683264.USD","IE000SO60NU8.SGD","LU0965509101.SGD","IE00BLSP4239.USD","LU1699723380.USD","IE0001KFT4U8.USD","BK4533","LU1221951129.SGD","BK4504","IE0034235303.USD","BK4585","LU2750360997.AUD","LU1721429402.USD","LU0170899867.USD","LU0861579265.USD","BK4516","LU0820562030.AUD","LU1162221912.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU2357627491.SGD","LU2129689514.USD","BK4007","MRK","LU0265550946.USD","LU1057294990.SGD","SGXZ41872573.SGD","SG9999015358.SGD","LU2237443622.USD","LU1674673691.USD","IE00BBT3K403.USD","LU1221951046.USD","IE00BVYPNV92.GBP","LU1929549753.HKD","LU1941712348.USD","LU2023250330.USD","LU0211331839.USD","LU2756315318.SGD","LU0689472784.USD","LU1059921491.USD","LU1228905037.USD","LU2417539215.USD","LU0345769631.USD","LU2129689605.HKD","LU2237443895.HKD","LU2456880835.USD","LU2592432038.USD","LU1721429741.USD","LU1043141123.HKD","LU1983299246.USD","LU0266013472.USD","LU2491050154.USD","LU0058720904.USD","LU2403377893.USD","LU1934455277.USD","LU1116320737.USD","LU2125154935.USD","IE0000B7K699.USD","LU0432979614.USD","LU1035773651.USD","LU1291159041.SGD","BK4532","LU1989772840.SGD","LU0320765992.SGD","LU1935042991.SGD","IE000BZT7R73.USD","LU2462157665.USD","LU0965509010.AUD","LU1032955483.USD","LU0985320562.USD","LU0208291251.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU1718418525.SGD","LU2361044865.SGD","LU1829250122.USD","LU1066051225.USD","AZNH","LU0098860793.USD","LU2213496289.HKD","BK4082","LU0545562505.USD","LU0942090050.USD","LU1732800096.USD","LU2471134952.CNY","IE000WAW04H5.SGD","LU2896262040.SGD","LU0320765489.SGD","LU0203347892.USD","LU0070302665.USD","LU1989771016.USD","LU2237443549.SGD","LU2361045086.USD","IE0009355771.USD","LU2491049909.HKD","BK4592","SG9999014542.SGD","LU2237957811.SGD","LU0868494708.USD","LU0426417589.USD","LU2237443978.SGD","IE00B3T34201.USD","LU2756315664.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","LU2491050071.SGD","SG9999002232.USD","GSK.UK","SG9999002224.SGD","LU1989772923.USD","IE0002141913.USD","LU1261432733.SGD","BK4559","IE00BJT1NW94.SGD","SG9999015341.SGD","IE00B19Z3B42.SGD","LU0795875169.SGD","LU1914381329.SGD","LU2461242641.AUD","LU1121112475.USD","LU1430594728.SGD","LU0980610538.SGD","IE00BN8TJ469.HKD","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","LU1629891620.HKD","LU0889565916.HKD","LU1551013425.SGD","BK4550","LU1934455863.HKD","SG9999013999.USD","BK4581","LU1496350502.SGD","SG9999001440.SGD","LU2430703251.USD","BK4588","LU0114720955.EUR","LU0130102774.USD","LU1061106388.HKD","LU1244550221.USD","IE00BFTCPJ56.SGD","BK4566","LU2112291526.USD","LU0345770308.USD","LU0477156953.USD","LU1093756168.USD","LU1093756325.SGD","LU0289739699.SGD","LU1037948541.HKD","LU0882574055.USD","LU2089984988.USD","LU2360032135.SGD","SG9999001176.USD","LU0994945656.USD","LU1571399168.USD","LU0210536198.USD","LU0795875086.SGD","LU1074936037.SGD","LU2602419157.SGD","IE00BFXG1179.USD","LU1043141396.HKD","LU1244550494.USD","SG9999014567.USD","LU1989763427.SGD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU0820561909.HKD","LU1551013342.USD","LU1032466523.USD","IE00B19Z3581.USD","LU2125154778.USD","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU1989763690.USD","LU1732799900.SGD","LU2487616109.SGD","LU0345770993.USD","LU2430703095.HKD","LU0238689110.USD","LU2324357040.USD","IE000F7OJYX1.SGD","LU1023059063.AUD","LU2023250843.SGD","LU2471134523.USD","LU0964807845.USD","LU1585245621.USD","LU0345769128.USD","LU1506573853.SGD","IE00B42XCP33.USD","SG9999001176.SGD","LU0053666078.USD","LU0130517989.USD","LU0234570918.USD","LU0859254822.USD","LU0868494617.USD","LU1280957306.USD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2634338289","title":"中國生物製藥升逾4%：牽手GSK合作乙肝臨床治癒明星產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2634338289","media":"澎湃新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634338289?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 19:58","pubTimestamp":1778500680,"startTime":"0","endTime":"0","summary":"全球首款有望最快实现乙肝功能性治愈的重磅药物被中国生物制药收入囊中！5月11日，中国生物制药（1177.HK）正式宣布，核心子公司正大天晴药业集团与知名跨国药企葛兰素史克（LSE/NYSE：GSK）达成独家战略合作，将加速一款名为bepirovirsen的药物在中国的上市进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733296932.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733296932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BZ08YR35.GBP","BK4588","BK1589","BK1191","BK1515","BK4007","GSK","GSKH","LU1829250122.USD","BK4585","IE00BZ08YT58.USD","BK4532","IE00BZ08YS42.EUR","HK0000165453.HKD","GSK.UK","01177","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634405436","title":"正大天晴牽手GSK，瞄準乙肝百億美元賽道商業化棋局","url":"https://stock-news.laohu8.com/highlight/detail?id=2634405436","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634405436?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 15:26","pubTimestamp":1778484360,"startTime":"0","endTime":"0","summary":"中国乙肝治疗药物市场正在迎来一个关键变量。5月11日，中国生物制药（1177.HK）公告，其核心子公司正大天晴与葛兰素史克（GSK）就反义寡核苷酸（ASO）药物Bepirovirsen达成独家战略合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113733015888.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113733015888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4532","GSK.UK","BK4588","GSKH","LU1829250122.USD","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634847134","title":"中國生物製藥牽手葛蘭素史克 佈局乙肝新藥在華商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=2634847134","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634847134?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 12:34","pubTimestamp":1778474040,"startTime":"0","endTime":"0","summary":"5月11日，中国生物制药（01177）发布公告，附属公司正大天晴与葛兰素史克达成独家战略合作，加速bepirovirsen在中国内地的上市进程。根据协议，正大天晴将负责bepirovirsen在中国内地的进口、分销、医院准入以及推广和非推广活动，产生的全部销售收入将确认为正大天晴的营业收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605113732881024.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605113732881024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1521","HK0000165453.HKD","BK1191","BK4588","BK4532","IE00BZ08YT58.USD","BK4007","BK1515","GSK.UK","BK4585","LU1829250122.USD","BK1589","01177","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633512166","title":"時安生物與GSK就寡核苷酸新藥達成超10億美元授權合作；莎普愛思終止購買上海勤禮實業100%股權｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2633512166","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633512166?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 07:00","pubTimestamp":1778108408,"startTime":"0","endTime":"0","summary":"丨2026年5月7日星期四丨NO.1时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作时安生物宣布，与葛兰素史克（GSK）就SA030达成一项中国市场以外的全球独家许可协议。葛兰素史克将支付首付款，以及未来基于成功达成的开发、注册与商业化里程碑付款，总额最高达10.05亿美元；同时将按中国以外的全球产品净销售额支付分级特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605073729101163.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073729101163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1574","603168","BK4532","BK4585","BK1161","09939","BK1515","GSKH","LU1829250122.USD","BK4588","159938","GSK","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631440005","title":"葛蘭素史克(GSK)股票4月29日盤中下跌5.22%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2631440005","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631440005?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 01:17","pubTimestamp":1777483043,"startTime":"0","endTime":"0","summary":"• 尽管销售强劲并重申了业绩指引，GSK股价仍出现下跌。\n• 每股收益低于分析师预期，引发了市场的负面反应。\n• 法律拨备及对老牌药物的担忧影响了投资者信心。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261838095-market-movers-gsk-20260429","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","GSKH","GSK.UK","LU1829250122.USD","BK4585","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":95,"code":"91000000","status":"200"}]}}